Lakhanpur among first towns selected under PM SVANidhi 'Street Food Hub' Plan: MoS (See 'Corp Brief') Paswan hails PMFME Scheme's landmark achievement of 2 lakh Credit-Linked Beneficiaries (See 'Corp Brief') IPR - If on visual comparison, rival medicinal marks are strikingly similar in essential features, overall get up and packaging, and where trade channels and consumer base are common, likelihood of deception is sufficient to justify interim injunction: HC (See 'Legal Desk') 500 officials participate in inaugural webinar on Anemia and Adolescent Health (See 'Corp Brief') IPR - Purpose of summary judgment in commercial suits is to ensure time-bound disposal and that trial is not default norm: HC (See 'Legal Desk') Ministry of Textiles to organise 'Weave The Future 4.0 - Upcycling Edition' at Dilli Haat (See 'Corp Brief') Nadda chairs Steering Group Meeting of Ayushman Bharat Digital Mission (See 'Corp Brief') DoP and TRAI to conduct Village-Level Telecom Network Performance Survey (See 'Corp Brief') Department of Commerce reviews Andhra FCV Tobacco Marketing Season 2025-26 (See 'Corp Brief') Minister inaugurates Centre of Excellence on Human-Wildlife Conflict at WII-SACON (See 'Corp Brief') ITADCs to emerge as one-stop growth hubs for Textile Entrepreneurs: Giriraj Singh (See 'Corp Brief') NMCG's focus on Nature Based Solutions: Initiation of two pilot projects and training programs on NbS (See 'Corp Brief') IPR - For purposes of Sec 57 of Trade Marks Act, foreign proprietor may succeed in rectification by proving that its mark had acquired actionable recognition, even without formal commercial launch or direct sales: HC (See 'Legal Desk') Insurance Division, DFS, secures 2nd Rank in Group A Category Grievance Redressal Assessment (See 'Corp Brief') Standing Committee of National Board for Wildlife reviews progress on Key Conservation Initiatives (See 'Corp Brief') BharatNet-enabled integrated phygital service delivery model secures global honour (See 'Corp Brief') IBC - Demand notice in Form B under Rule 7(1) of Personal Guarantor Rules is only procedural requirement prior to filing and does not amount to invocation of guarantee: NCLT (See 'Legal Desk') Shivraj Singh Chouhan, Taliban minister discuss agricultural ties (See 'Corp Brief') Union Ministry Launches Integrated Training for Primary Healthcare Teams (See 'Corp Brief') Advancing Women's Leadership at Grassroots, held as part of BRICS Women Ministerial Meeting in Kochi (See 'Corp Brief') SARFAESI - Borrowers who fail to timely invoke MSME framework are precluded from seeking its protection at belated stage after SARFAESI proceedings have commenced: HC (See 'Legal Desk') Bhubaneswar Declaration charts roadmap to transform Tribal Research Institutes into centres of excellence (See 'Corp Brief') TEC signs MoU with BECIL to strengthen Telecom and Broadcasting Ecosystem (See 'Corp Brief') NLDSL and Punjab sign MoU to strengthen Digital Logistics Ecosystem (See 'Corp Brief') Competition Act - OP entered into anti-competitive agreements & abused its dominant position by imposing unfair & restrictive conditions on participants in its beauty pageant, in contravention of Sections 3 & 4 - D-G to probe matter: CCI (See 'Legal Desk') Kamarajar Port becomes India's Second Major Port with 18-Metre Draft Capability (See 'Corp Brief') Large-Scale Infrastructure Expansion opens up Opportunities for Budding Engineers (See 'Corp Brief') CCI okays merger of 51 Malabar Group's companies into Malabar Gold and Diamonds Ltd (See 'Corp Brief') IBC - Delayed creation of security cannot be treated as transaction in normal course of business: NCLAT (See 'Legal Desk') CCI approves acquisition of equity in Sorting Hat Technologies and merger into upGrad Education (See 'Corp Brief') Atal Innovation Mission Strengthens Eastern India Innovation Ecosystem (See 'Corp Brief') Giriraj Singh to inaugurate 'Indie Haat 2026' (See 'Corp Brief') IBC - Rent Tribunal lacks jurisdiction in cases involving entities undergoing CIRP, per Sections 60(5)(c) & 238 of IBC, which confer exclusive jurisdiction upon the Adjudicating Authority in CIRP matters: NCLT (See 'Legal Desk') Labour Ministry translates objectives of Labour Codes to provide timely relief to workers (See 'Corp Brief') Trade Marks - Mark KREOFLAT is distinctively similar to existing mark of PANKREOFLAT where former copies essential & distinctive features of latter, thereby making the former visually, phonetically & deceptively similar: HC (See 'Legal Desk') CAQM reports 62 air pollution violations across NCR in 17 days; proposes closure of four units (See 'Corp Brief') Utsav & Chintan Shivir 2026 to focus on institutional reforms for a technology-driven, and citizen-centric legal ecosystem (See 'Corp Brief') Sukesh Chandrashekhar con saga - co-accused gets bail - stringent conditions of Section 45 of PMLA can be relaxed for women, more so considering extraordinary circumstances: HC (See 'Legal Desk') Govt raises onion procurement price by 13% to Rs.2,125 per quintal (See 'Corp Brief') India's last 12 years have been a progression from shortages to building Viksit Bharat: RM (See 'Corp Brief') SARFAESI - Writ jurisdiction under Article 226 should ordinarily not be exercised where efficacious alternative remedy exists, particularly in matters arising under the SARFAESI Act: HC (See 'Legal Desk') India's youth will power AI, robotics with Made in India chips: PM (See 'Corp Brief') Competition Act - Allegations relating to use of private vehicles without commercial permits, non-compliance with Motor Vehicles Act, opaque GST & STA tax practices, & related issues fall outside scope of Competition Act: CCI (See 'Legal Desk') Tech Innovation and disruption in Construction Industry (See 'CORP EINSICHT')

Print

Govt hosts workshop on increasing R&D in pharma-medical tech sector

Published: Mar 13, 2025

By TIOLCorplaws News Service

NEW DELHI, MAR 13, 2025: THE Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, organised a workshop on the Promotion of Research and Innovation in Pharma-MedTech Sector (PRIP) Scheme today. The workshop was inaugurated in the presence of the Secretaries of five stakeholder Ministries and Departments of the Government of India, namely, Amit Agrawal, Secretary, Department of Pharmaceuticals; Prof. Abhay Karandikar, Secretary, Department of Science and Technology (DST); S. Krishnan, Secretary, Ministry of Electronics and Information Technology (MeitY); Dr N. Kalaiselvi, Secretary, Department of Scientific and Industrial Research (DSIR) and Director General (DG), Council of Scientific and Industrial Research (CSIR); and Dr Rajiv Bahl, Secretary, Department of Health Research (DHR) and DG, Indian Council for Medical Research (ICMR). The workshop served as a platform for identifying key action points and approaches to further the shared commitment to promote research and development in the pharmaceuticals and medical technologies sector.

Amit Agrawal, Secretary, Department of Pharmaceuticals highlighted the rapid expansion in the sector, underscoring the importance of research and innovation in driving making and innovating in India for India and the world. In this regard, he highlighted that the global share of personalised and precision technology platforms (such as antibody-drug conjugates, bi-specific antibodies, and cell and gene therapy) among the top-100 drugs by value is growing rapidly, from 5% in 2020 to 9% in 2025 and projected to grow to 20% by 2030. He also highlighted the 10 times increase in the number of Indian healthcare and life sciences startups over the last four years, from over 900 in 2020 to more than 10,000 in 2024, as well as the growing pipeline of innovative products of Indian firms.

Amit Agrawal said that the groundwork and the pipeline for projects for the PRIP scheme has been laid through this growing innovation ecosystem of Indian startups and industry, supported by a wide array of initiatives of the scientific Ministries/ Departments. The latter include the clinical trial network created by CSIR under its INTENT initiative; the patenting support available through DST's TIFAC and ICMR's Patent Mitra initiative; the handholding support available to both medical technology and drug innovations through ICMR's MedTech Mitra initiative; the funding support available to startups through Department of Biotechnology's BIRAC, MeitY's TIDE 2.0 and SAMRIDH schemes and DST's Quantum Computing Mission, etc.

Reiterating the Government's commitment to a robust research ecosystem, Amit said that PRIP is a transformative initiative aimed at catalysing innovation, strengthening industry-academia linkages, and positioning India as a global leader in pharmaceutical and MedTech research.

Prof. Abhay Karandikar, Secretary, DST underscored the importance of cutting-edge scientific research in driving advancements in pharmaceuticals and MedTech, reinforcing India's healthcare ecosystem and highlighted the supports available through the extensive incubator and accelerator network of DST.

S. Krishnan, Secretary, MeitY emphasised the transformative potential of digital health, artificial intelligence (AI) and data-driven technologies in drug discovery and medical device development. He highlighted the research strengths of MeitY's organisations, such as Society for Applied Microwave Electronics Engineering and Research (SAMEER), C-DAC and Centre for Materials for Electronics Technology (C-MET).

Dr Rajiv Bahl, Secretary, DHR and DG, ICMR highlighted the critical role of clinical research, indigenous drug development and regulatory advancements in accelerating pharmaceutical innovation. He offered the full support of the ICMR INTENT, MedTech Mitra and Patent Mitra initiatives in taking forward the shared goals of PRIP scheme. He also said that the industry-academia collaborative research window under the scheme could be of considerable help in taking forward the large volume of intramural and extramural research being funded by ICMR to the market with funding from PRIP and industry involvement.

Dr N. Kalaiselvi, Secretary, DSIR and DG, CSIR underscored the need to foster a culture of scientific collaboration between research institutions and industry to ensure the seamless translation of research into commercially viable applications. She highlighted that considerable research done in CSIR labs could be taken to the market through collaboration with industry and funding from PRIP.

The discussions reaffirmed the Government's vision of transforming India into a global hub for research and innovation in pharmaceuticals and medical technology. The workshop featured four dedicated breakout sessions, bringing together over 100 participants from leading scientific departments and premier institutions, including the National Institutes of Pharmaceutical Education and Research, IITs, CSIR labs and organisations of ICMR, MeitY, DST and Department of Bio technology, along with key government enablers for the ecosystem. Key deliberations covered the emerging trends in pharmaceutical and MedTech research, strategies for translating research into commercially viable products, government support mechanisms to accelerate sectoral growth and flexibilities sought to maximise the impact from the PRIP scheme.

All participants were requested to share their suggestions in the Expression of Interest (EoI) form for the PRIP scheme hosted on the website of the Department of Pharmaceuticals, so that these may be taken into account while taking forward the scheme and enabling participants. The EoI would be open till April 7, 2025.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.